Stockscreener 앱 받기
10.29
0.29%
0.03
시간 외 거래:
10.29
전일 마감가:
$10.26
열려 있는:
$10.29
하루 거래량:
101
Relative Volume:
0.00
시가총액:
$344.89M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.29%
1개월 성능:
+0.19%
6개월 성능:
+3.31%
1년 성능:
+0.00%
1일 변동 폭
$10.29
$10.29
1주일 범위
$10.25
$10.29
52주 변동 폭
$9.96
$10.29
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
명칭
Drugs Made In America Acquisition Corp
전화
954-870-3104
주소
2 PELICAN DR., FORT LAUDERDALE
DMAA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.29 | 343.89M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.30 | 1.80B | 3.13B | -174.20M | -111.20M | -0.6688 |
|
AACT
Ares Acquisition Corporation Ii
|
11.41 | 705.82M | 0 | 16.92M | -1.35M | 0.29 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
9.93 | 587.28M | 0 | 0 | 0 | 0.00 |
|
AAM
Aa Mission Acquisition Corp
|
10.48 | 460.41M | 0 | 0 | 0 | 0.00 |
|
CCCX
Churchill Capital Corp X
|
10.12 | 526.49M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp 주식(DMAA)의 최신 뉴스
Can Drugs Made In America Acquisition Corp. reach all time highs this yearWeekly Trend Recap & Weekly High Potential Stock Alerts - khodrobank.com
Is Drugs Made In America Acquisition Corp. stock undervalued right nowPortfolio Return Report & Real-Time Buy Signal Notifications - khodrobank.com
What is the next catalyst for Drugs Made In America Acquisition Corp. Equity Right2025 Retail Activity & Precise Swing Trade Alerts - khodrobank.com
Utilities Corp. meet Warren Buffett’s criteria2025 Year in Review & Weekly Watchlist of Top Performers - khodrobank.com
Quantitative breakdown of Drugs Made In America Acquisition Corp. recent move2025 Key Lessons & Capital Efficiency Focused Strategies - Newser
Will Drugs Made In America Acquisition Corp. bounce back from current support2025 Breakouts & Breakdowns & Growth Focused Stock Pick Reports - Newser
Real time social sentiment graph for Drugs Made In America Acquisition Corp.Weekly Market Report & AI Forecasted Entry/Exit Points - Newser
What does recent volatility data suggest for Drugs Made In America Acquisition Corp.Trade Exit Summary & Risk Controlled Stock Alerts - Newser
Drugs Made In America Acquisition Corp. stock volume spike explainedJuly 2025 Action & Weekly Setup with High ROI Potential - Newser
Short interest data insights for Drugs Made In America Acquisition Corp. Equity RightSell Signal & AI Powered Market Entry Strategies - Newser
Will Drugs Made In America Acquisition Corp. Equity Right stock go up soonTrade Analysis Summary & Free High Return Stock Watch Alerts - Newser
Applying Elliott Wave Theory to Drugs Made In America Acquisition Corp. Equity RightTrade Ideas & Fast Moving Stock Watchlists - Newser
Is Drugs Made In America Acquisition Corp. stock reversal real or fake2025 Major Catalysts & Real-Time Stock Entry Alerts - Newser
How hedge fund analytics apply to Drugs Made In America Acquisition Corp. Equity Right stockWeekly Trade Recap & Risk Controlled Swing Trade Alerts - Newser
Visualizing Drugs Made In America Acquisition Corp. stock with heatmapsJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
Is it too late to sell Drugs Made In America Acquisition Corp. Equity Right2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - Newser
Measuring Drugs Made In America Acquisition Corp. Equity Right’s beta against major indices2025 Bull vs Bear & Stock Timing and Entry Methods - Newser
Analyzing drawdowns of Drugs Made In America Acquisition Corp. Equity Right with statistical toolsAnalyst Downgrade & Weekly Setup with ROI Potential - Newser
Can machine learning forecast Drugs Made In America Acquisition Corp. Equity Right recoveryJuly 2025 Market Mood & Weekly Setup with High ROI Potential - Newser
Does Drugs Made In America Acquisition Corp. qualify in momentum factor screeningWeekly Profit Summary & Risk Managed Investment Strategies - Newser
Institutional scanner results for Drugs Made In America Acquisition Corp.Swing Trade & Weekly High Conviction Ideas - Newser
Has Drugs Made In America Acquisition Corp. Equity Right formed a bullish divergence2025 Market Sentiment & Fast Entry High Yield Tips - Newser
Relative strength of Drugs Made In America Acquisition Corp. in sector analysisMarket Performance Report & AI Powered Buy and Sell Recommendations - Newser
Real time scanner hits for Drugs Made In America Acquisition Corp. explainedJuly 2025 Outlook & Community Supported Trade Ideas - Newser
Can Drugs Made In America Acquisition Corp. Equity Right recover in the next quarterJuly 2025 Patterns & Daily Technical Stock Forecast Reports - Newser
Leading vs lagging indicators on Drugs Made In America Acquisition Corp. Equity Right performanceBuy Signal & Momentum Based Trading Ideas - Newser
Is Drugs Made In America Acquisition Corp. forming a bottoming baseDip Buying & Fast Momentum Stock Entry Tips - Newser
Is this a good reentry point in Drugs Made In America Acquisition Corp. Equity RightJuly 2025 Highlights & Reliable Breakout Forecasts - Newser
Real time scanner hits for BLFY explainedWeekly Trend Summary & Weekly High Return Stock Opportunities - Newser
Real time scanner hits for SEALSQ Corp explainedEarnings Miss & Short-Term High Return Strategies - Newser
Trend analysis for Drugs Made In America Acquisition Corp. this weekProduct Launch & High Return Stock Watch Alerts - Newser
Is a relief rally coming for Drugs Made In America Acquisition Corp. holdersJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Risk adjusted return profile for Energy Focus Inc. analyzedEarnings Growth Report & Growth Focused Stock Pick Reports - Newser
Risk vs reward if holding onto Drugs Made In America Acquisition Corp. - Newser
Published on: 2025-09-02 00:52:21 - Newser
How to escape a deep drawdown in Drugs Made In America Acquisition Corp. Equity Right2025 Price Targets & Verified Chart Pattern Trade Signals - Newser
Heatmap analysis for Drugs Made In America Acquisition Corp. and competitorsTrade Signal Summary & Long-Term Safe Investment Plans - Newser
Published on: 2025-09-01 22:44:37 - Newser
Is Drugs Made In America Acquisition Corp. currently under institutional pressureTrade Performance Summary & AI Driven Stock Price Forecasts - khodrobank.com
Is Drugs Made In America Acquisition Corp. Equity Right a candidate for recovery playJuly 2025 Retail & Smart Allocation Stock Tips - Newser
Will Drugs Made In America Acquisition Corp. Equity Right price bounce be sustainable2025 Price Momentum & Consistent Income Trade Ideas - Newser
Candlestick signals on SBLK stock todayJuly 2025 Breakouts & Capital Protection Trading Alerts - Newser
How to manage a losing position in Bold Eagle Acquisition Corp. Debt Equity Composite Units2025 Price Action Summary & Breakout Confirmation Alerts - Newser
Analyzing net buyer seller activity in Drugs Made In America Acquisition Corp. Equity Right2025 Geopolitical Influence & Long Hold Capital Preservation Tips - Newser
Is Drugs Made In America Acquisition Corp. Equity Right gaining market shareMarket Activity Report & Verified Chart Pattern Signals - khodrobank.com
Combining price and volume data for Drugs Made In America Acquisition Corp. Equity RightTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - Newser
Can Drugs Made In America Acquisition Corp. Equity Right be the next market leaderJuly 2025 Levels & Weekly Stock Breakout Alerts - khodrobank.com
Wyckoff Accumulation Phase Possible in Drugs Made In America Acquisition Corp. getLinesFromResByArray error: size == 0 - thegnnews.com
Drugs Made In America Acquisition Corp. Building a Base Near Support getLinesFromResByArray error: size == 0 - kangso.co.kr
EPS Watch: Can Drugs Made In America Acquisition Corp. reach all time highs this yearJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - khodrobank.com
Smart tools for monitoring Drugs Made In America Acquisition Corp.’s price actionDay Trade & Free Risk Controlled Daily Trade Plans - Newser
Drugs Made In America Acquisition Corp (DMAA) 재무 분석
Drugs Made In America Acquisition Corp (DMAA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.10%
0.10%
자본화:
|
볼륨(24시간):